Significance of a Tumor Mutation Burden Gene Signature with Prognosis and Immune Feature of Gastric Cancer Patients

Figure 3

(a) Predictive function of the risk signature in testing set. Kaplan-Meier analysis was conducted to determine survival difference between the high-risk group and the low-risk group. (b, c) Receiver operating characteristic (ROC) curve was plotted to assess the accuracy of the signature in predicting patients’ survival outcomes. (d, e) Patients were ranked according to risk score value, and the survival status of the patients was visualized. (f) A heatmap was plotted to visualize the expression pattern difference of the genes in the signature between the high-risk group and the low-risk group.

(a)

(b)

(c)

(d)

(e)

(f)